Analysis of U.S. national burn registry data demonstrates 36% shorter hospital stays in adults with deep second-degree burns treated with RECELL versus traditional skin graftingMore than $42,000 per patient cost savings, together with improved patient throughput, support operational and economic value Presented at the 2025 European Burn Association Congress in Berlin, Germany VALENCIA, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound ...